EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 Annual Balance Sheet

EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 Annual Balance Sheet

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

Assets

13,055,300,000 US dollars

Current assets

6,285,400,000 US dollars

Non-current assets

6,769,900,000 US dollars

Liabilities

2,992,400,000 US dollars

Current liabilities

1,505,200,000 US dollars

Non-current liabilities

1,487,200,000 US dollars

Equity

10,062,900,000 US dollars

Noncontrolling interest

64,500,000 US dollars. Included in consolidated equity; this amount is not added again.

Cash and cash equivalents

3,045,200,000 US dollars

Inventories (Note 6)

1,086,700,000 US dollars

Short-term investments (Note 8)

930,700,000 US dollars

Accounts receivable, net of allowances of $11.6 and $8.2, respectively

609,100,000 US dollars

Other current assets

347,600,000 US dollars

Prepaid expenses

121,000,000 US dollars

Other receivables

118,300,000 US dollars

Current assets of discontinued operations (Note 5)

26,800,000 US dollars

Goodwill (Note 11)

1,776,700,000 US dollars

Property, plant, and equipment, net (Note 6)

1,686,000,000 US dollars

Other intangible assets, net (Note 11)

1,176,600,000 US dollars

Deferred income taxes

992,100,000 US dollars

Other assets

721,600,000 US dollars

Long-term investments (Note 8)

307,900,000 US dollars

Operating lease right-of-use assets (Note 7)

98,200,000 US dollars

Non-current assets of discontinued operations (Note 5)

10,800,000 US dollars

Accrued and other liabilities (Note 6)

1,282,400,000 US dollars

Accounts payable

197,400,000 US dollars

Operating lease liabilities (Note 7)

23,400,000 US dollars

Current liabilities of discontinued operations (Note 5)

2,000,000 US dollars

Long-term debt (Note 12)

597,700,000 US dollars

Uncertain tax positions (Note 19)

384,600,000 US dollars

Other liabilities

357,500,000 US dollars

Operating lease liabilities (Note 7)

78,900,000 US dollars

Litigation settlement accrual (Note 3)

52,700,000 US dollars

Contingent consideration liabilities (Note 13)

14,500,000 US dollars

Taxes payable (Note 19)

1,300,000 US dollars

Non-current liabilities of discontinued operations (Note 5)

0 US dollars

Retained earnings

13,167,000,000 US dollars

Additional paid-in capital

2,613,400,000 US dollars

Common stock, $1.00 par value, 1,050.0 shares authorized, 654.8 and 650.5 shares issued, and 588.6 and 601.1 shares outstanding, respectively

654,800,000 US dollars

Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding

0 US dollars

Noncontrolling interest

64,500,000 US dollars

Treasury stock, at cost, 66.2 and 49.4 shares, respectively

negative 6,192,300,000 US dollars

Accumulated other comprehensive loss (Note 17)

negative 244,500,000 US dollars

Gross equity (calculated)

16,499,700,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.